Beam Therapeutics (BEAM) Stock Forecast & Price Target

BEAM$22.83-1.20 -4.99%
BiotechnologyGrowth Stock
Compare
Market cap$2.36BEnterprise value$2.90BRevenue (TTM)$146.64MMarket position—

Score

68
Bullish
Value
58
Quality
45
Growth
100

Beam Therapeutics Inc. price target

BEAM
Low$39.00
Average$66.00
High$80.00
Upside vs current price+189.1%

The average target of $66.00 is +189.1% versus the current BEAM price of $22.83.

Beam Therapeutics Inc. analyst ratings

RatingAnalysts
Strong buy1
Buy12
Hold2
Sell0
Strong sell0
ConsensusBuy

15 analysts cover BEAM.

Beam Therapeutics Inc. EPS and revenue estimates

The estimate table for the Beam Therapeutics Inc. keeps 2026 EPS $-4.44, 2027 EPS $-4.82, and years with fewer than three analysts are not filled in.

Fiscal yearEPS estimateRevenue estimate
2026$-4.44$51.24M
2027$-4.82$62.27M

Is Beam Therapeutics Inc. a buy or sell?

Of the 15 analysts covering Beam Therapeutics Inc., 13 rate it a buy (1 strong buy and 12 buy), 2 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The BEAM consensus label is Buy, beside 13 buy-side ratings and 0 sell-side ratings.

The average target of $66.00 implies +189.1% versus the current price of $22.83.

the Beam Therapeutics Inc. closes with 13 buy-side ratings and 0 on the sell side. The headcount is Buy.

Reading the Beam Therapeutics Inc. forecast

Analysts are far apart on BEAM. The published low is $39.00, the average is $66.00, and the high is $80.00.

From today's $22.83 print, the BEAM average target is +189.1% away.

Most of the BEAM coverage agrees: 13 of 15 analysts are on the buy side, 2 are at hold, and 0 are on the sell side, and the published consensus is Buy.

BEAM targets have not moved much: $79.00 recently, $79.00 across the quarter.

Coverage of BEAM is broad at 15 analysts, and the average is a crowd rather than a single desk.

Beam Therapeutics Inc. forecast questions

What is the BEAM price target?

The published range for BEAM is $39.00 to $80.00, with an average of $66.00. That average is +189.1% versus the current price of $22.83.

Is Beam Therapeutics Inc. a buy or sell?

Of the 15 analysts covering Beam Therapeutics Inc., 13 rate it a buy, 2 rate it a hold, and 0 rate it a sell. The consensus is Buy, which for BEAM is 13 on the buy side, 2 at hold, and 0 on the sell side.

What is the EPS estimate for Beam Therapeutics Inc.?

Analyst EPS estimates for Beam Therapeutics Inc.: 2026 $-4.44, 2027 $-4.82.

What is the revenue estimate for Beam Therapeutics Inc.?

Analyst revenue estimates for Beam Therapeutics Inc.: 2026 $51.24M, 2027 $62.27M.

How many analysts cover BEAM?

15 analysts cover BEAM. Their consensus on BEAM is Buy, across those 15.

BEAM price $22.83 -1.20 -4.99%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener